This inventor holds 1 USPTO granted patent. Top assignees: Intelligent Synthetic Biology Center, Korea Advanced Institute of Science and Technology. Active years: 2019.
Company Filing History:
1 out of 20 
1 out of 2,787 
Years Active: 2019
Title: The Innovations of Soo Hwan Lim
Introduction
Soo Hwan Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of glycosylation, particularly in relation to ginsenosides derived from Panax ginseng. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Soo Hwan Lim holds a patent titled "Method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng." This invention relates to a uridine diphosphate (UDP)-glycosyltransferase protein that exhibits glycosylation activity for a hydroxyl group at the C-20 position of protopanaxadiol (PPD) or protopanaxatriol (PPT)-type ginsenosides. The method he developed for glycosylation of UDP using this protein showcases his innovative approach to enhancing the properties of ginsenosides.
Career Highlights
Throughout his career, Soo Hwan Lim has been associated with prestigious institutions such as the Korea Advanced Institute of Science and Technology and the Intelligent Synthetic Biology Center. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Soo Hwan Lim has collaborated with notable colleagues, including Sun Chang Kim and Gil Tsu Choi. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Soo Hwan Lim's contributions to the field of glycosylation and his innovative patent highlight his role as a significant inventor in biotechnology. His work continues to influence research and applications in the industry.